Abstract:Rationale Isomerism can be an important aspect in pharmaceutical drug development. Identification of isomers can provide insights into drug pharmacology and contribute to better design of drug molecules. The general approaches to differentiate isomers include Fourier‐transform infrared spectroscopy (FTIR), nuclear magnetic resonance (NMR), and circular dichroism. Additionally, a commonly used method to differentiate isomers is liquid chromatography coupled with mass spectrometry (LC‐MS). Notably, LC‐MS is routinely applied to leucine and isoleucine differentiation to facilitate protein sequencing. This work focuses on isomer differentiation of widely employed thio‐succinimide structure bridging the antibody backbone and linker‐payload of antibody‐drug conjugates (ADCs). Thio‐succinimide hydrolysis stabilizes the payload‐protein structure while generating a pair of constitutional isomers: thio‐aspartyl and thio‐isoaspartyl. Methods This paper introduces a hybrid method using ligand binding assay (LBA) and liquid chromatography coupled with tandem MS (LC–MS/MS) to reveal isomerization details of thio‐succinimide hydrolysis over time in plasma samples incubated with ADC. Application of two orthogonal dissociation methods, collision‐induced dissociation (CID) and electron‐activated dissociation (EAD) revealed different MS/MS spectra for this pair of isomers. This observation enables a unique approach in distinguishing thio‐succinimide hydrolysis isomers. Results We observed signature [R 1 + Thio + 57 + H] + , [R 2 + Succ + H 2 O − 57 + H] + , and [R 2 + Succ + H 2 O − 44 + 2H] 2+ product ions (Succ = succinimide) that differentiated thio‐aspartyl and thio‐isoaspartyl isomers using EAD. A newly discovered [R 2 + ThioSucc + H 2 O − 44 + 2H] 2+ ion also served as additional evidence that further supported our findings. Conclusions This study is a first‐to‐date identification of thio‐succinimide hydrolysis isomers without using synthesized reference materials. This approach should be applicable to all thio‐succinimide‐linked molecules. Correct identification of thio‐succinimide hydrolysis isomers may eventually benefit the development of ADCs in the future.

Reference‐free thio‐succinimide isomerization characterization by electron‐activated dissociation

Reference-Free Thio-Succinimide Isomerization Characterization by Electron-Activated Dissociation

Developing Analytical ion Exchange Chromatography Methods for Antibody Drug Conjugates Containing the Hydrolysis-Prone Succinimide-Thioether Conjugation Chemistry

In-depth characterization of a cysteine-linked ADC disitamab vedotin by multiple LC-MS analysis methods and cutting-edge imaged capillary isoelectric focusing coupled with native mass spectrometry

Tandem Mass Spectrometry Approaches for Differentiation and Quantification Pidotimod and Its Three Isomers in the Gas Phase

SEC-MS in denaturing conditions (dSEC-MS) for in-depth analysis of rebridged monoclonal antibody-based formats

Regioselective Synthesis And Electron Impact Mass Spectral Fragmentation Differentiation Of 2- Or 3-Isopropylthio, Phenylthiosuccinic Acid 4-Methyl/Isopropyl Ethers

N-propionyl thiosuccinimide linker upon hydrolysis becomes into a cleavable crosslinker by a gas phase metastable fragmentation and makes more reliable the conjugation sites identification.

Detailed Structural Elucidation of an Antibody-Drug Conjugate, AZD8205, Biotransformation Species Using LC-MRM with CID and EAD Fragmentation

An Automated and Qualified Platform Method for Site-Specific Succinimide and Deamidation Quantitation Using Low-pH Peptide Mapping

Differentiation of Oligosaccharide Isomers by Direct Infusion Multidimensional Mass Spectrometry

Utilizing ESI‐MS/MS and ion mobility spectrometry for structural characterization and isomer differentiation of 1, 2‐unsaturated (1‐4) linked disaccharide derivatives and their 2‐C‐functionalized analogues

Direct Differentiation of Stereoisomers of Ezetimibe/ambrisentan/atorvastatin and Their Mechanism Study by Electrospray Ionization Quadrupole Time-of-flight Mass Spectrometry

A combination of multiple LC-MS approaches for the comprehensive characterization of cysteine-linked ADCs

Direct Enantiomer Differentiation of Drugs and Drug-Like Compounds via Noncovalent Copper-Amino Acid Complexation and Ion Mobility-Mass Spectrometry

Discrimination of 3-Aminopyrrolidine Derivatives with Chiral and Positional Isomerism Through Mobility Disparity Based on Non-Covalent Interactions

Streamlining the Characterization of Disulfide Bond Shuffling and Protein Degradation in IgG1 Biopharmaceuticals Under Native and Stressed Conditions

Assigning Peptide Disulfide Linkage Pattern among Regio-Isomers Via Methoxy Addition to Disulfide and Tandem Mass Spectrometry

Multiplex Bioanalytical Methods for Comprehensive Characterization and Quantification of the Unique Complementarity-Determining-Region Deamidation of MEDI7247, an Anti-ASCT2 Pyrrolobenzodiazepine Antibody-Drug Conjugate

Rapid and Simultaneous Characterization of Drug Conjugation in Heavy and Light Chains of a Monoclonal Antibody Revealed by High-Resolution Ion Mobility Separations in SLIM

Separation and Characterization of Therapeutic Oligonucleotide Isomer Impurities by Cyclic Ion Mobility Mass Spectrometry